Skip to Main Content

Paper Details

Systemic immune changes accompany combination treatment with immunotoxin LMB-100 and nab-paclitaxel.
Cancer Med
3
2023
Author NameAffiliation
Yunkai YuNational Cancer Institute, National Institutes of Health
Yunkai YuNational Cancer Institute, National Institutes of Health
Seth M SteinbergNational Cancer Institute, National Institutes of Health
Seth M SteinbergNational Cancer Institute, National Institutes of Health
Liang CaoNational Cancer Institute, National Institutes of Health
Liang CaoNational Cancer Institute, National Institutes of Health
  • 1 - 6

Datasets

Release 1.2